Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer
Titel:
Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer
Auteur:
Puglisi, F. Cardellino, G.G. Crivellari, D. Di Loreto, C. Magri, M.D. Minisini, A.M. Mansutti, M. Andreetta, C. Russo, S. Lombardi, D. Perin, T. Damante, G. Veronesi, A.